Synthroid
Payments companies reported to CMS as associated with Synthroid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Synthroid, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Synthroid
These are the largest totals companies reported as associated with Synthroid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Tessnow | Dallas, TX | Endocrinology, Diabetes & Metabolism | $35,918.70 |
| David Gamble | American Fork, UT | Nurse Practitioner | $19,837.56 |
| Antonio Bianco | Chicago, IL | Endocrinology, Diabetes & Metabolism | $17,405.52 |
| Todd Frieze | Durham, NC | Endocrinology, Diabetes & Metabolism | $13,898.46 |
| Ralph Oiknine | Chesterfield, MO | Endocrinology, Diabetes & Metabolism | $11,900.69 |
| James Hennessey | Boston, MA | Endocrinology, Diabetes & Metabolism | $10,450.00 |
| Brittany Henderson | Mount Pleasant, SC | Endocrinology, Diabetes & Metabolism | $10,000.00 |
| Laura Kimball Ravari | Bossier City, LA | Endocrinology, Diabetes & Metabolism | $9,847.16 |
| Majd Hakim | Frederick, MD | Endocrinology, Diabetes & Metabolism | $9,782.63 |
| Ben Seale | Jackson, MS | Endocrinology, Diabetes & Metabolism | $9,701.11 |
Prescribed Synthroid?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.